Virtual Visitation in Intensive Care Unit Study (ISEEU)
Primary Purpose
Critically Ill Patients
Status
Unknown status
Phase
Not Applicable
Locations
Korea, Republic of
Study Type
Interventional
Intervention
Virtual meeting between patients/physicians and caregiver
Sponsored by
About this trial
This is an interventional supportive care trial for Critically Ill Patients
Eligibility Criteria
Inclusion Criteria:
- Patients who are expected to stay in the intensive care unit for more than 48 hours
- Patients with a RASS score of -2 or higher
Exclusion Criteria:
- Patients who discharge or die within 48 hours of admission to ICU
Sites / Locations
- Seoul National University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
No Intervention
Arm Label
Virtual visitation group
Control group
Arm Description
Virtual visits between patients-caregivers and virtual interviews between physicians-caregivers for 15minutes once a day
Phone interview between physicians-caregivers once a day
Outcomes
Primary Outcome Measures
FS-ICU score from caregivers at discharge or 7 days after initiation of study enrolled
The FS-ICU survey score reflected the satisfaction degree of caregivers. The overall satisfaction score is derived from questions 1 through 24.
Secondary Outcome Measures
Full Information
NCT ID
NCT04962204
First Posted
July 5, 2021
Last Updated
October 12, 2021
Sponsor
Seoul National University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT04962204
Brief Title
Virtual Visitation in Intensive Care Unit Study
Acronym
ISEEU
Official Title
Efficacy of Virtual Visitation in Intensive Care Unit During COVID-19 Pandemic: Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
October 2021
Overall Recruitment Status
Unknown status
Study Start Date
July 6, 2021 (Actual)
Primary Completion Date
March 31, 2022 (Anticipated)
Study Completion Date
June 30, 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Seoul National University Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
The purpose of this study is to identify the efficacy of virtual visitation in Intensive Care Unit on patients and their caregivers during COVID-19 Pandemic.
Detailed Description
After being informed about the study, all patients who meet the eligibility requirements will be randomized in a 1:1 ratio to intervention group (Virtual visitation once a day) or Control group (Phone interviews once a day).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Critically Ill Patients
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Interventional group Control group
Masking
None (Open Label)
Allocation
Randomized
Enrollment
100 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Virtual visitation group
Arm Type
Active Comparator
Arm Description
Virtual visits between patients-caregivers and virtual interviews between physicians-caregivers for 15minutes once a day
Arm Title
Control group
Arm Type
No Intervention
Arm Description
Phone interview between physicians-caregivers once a day
Intervention Type
Behavioral
Intervention Name(s)
Virtual meeting between patients/physicians and caregiver
Intervention Description
Virtual visits between patients-caregivers and virtual interviews between physicians-caregivers for 15minutes once a day
Primary Outcome Measure Information:
Title
FS-ICU score from caregivers at discharge or 7 days after initiation of study enrolled
Description
The FS-ICU survey score reflected the satisfaction degree of caregivers. The overall satisfaction score is derived from questions 1 through 24.
Time Frame
7 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients who are expected to stay in the intensive care unit for more than 48 hours
Patients with a RASS score of -2 or higher
Exclusion Criteria:
Patients who discharge or die within 48 hours of admission to ICU
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Seung-Young Oh
Phone
+82-2-2072-3538
Email
faun1226@gmail.com
Facility Information:
Facility Name
Seoul National University Hospital
City
Seoul
State/Province
Jongno-gu
ZIP/Postal Code
03080
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Seoul National University Hospital
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Virtual Visitation in Intensive Care Unit Study
We'll reach out to this number within 24 hrs